Suppr超能文献

慢性阻塞性肺疾病肺泡巨噬细胞引起的中性粒细胞趋化作用:CXCL8 和受体 CXCR1/CXCR2 的作用。

Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.

机构信息

University of Manchester, Institute of Inflammation & Repair, University Hospital of South Manchester Foundation Trust, Manchester, United Kingdom.

出版信息

J Pharmacol Exp Ther. 2013 Oct;347(1):173-80. doi: 10.1124/jpet.112.201855. Epub 2013 Aug 2.

Abstract

Alveolar macrophages produce neutrophil chemoattractants; this cellular cross-talk contributes to neutrophilic airway inflammation in chronic obstructive pulmonary disease (COPD). We have investigated the chemotaxis cross-talk mechanisms between these cells using COPD alveolar macrophages. Using conditioned media from stimulated COPD alveolar macrophages, we investigated the relative contributions of growth-related oncogene (CXCL1), interleukin-8 (CXCL8), and regulated on activation normal T cell expressed and secreted (CCL5) to neutrophil chemotaxis and evaluated the effect of blocking the chemokine receptors CXCR1 and CXCR2 on chemotaxis caused by macrophage-conditioned media. Furthermore, we evaluated whether corticosteroid treatment of stimulated alveolar macrophages inhibited the chemotaxis ability of conditioned media. Alveolar macrophages isolated from COPD (n = 8) and smoker (S) (n = 8) lungs were treated with ultra-pure lipopolysaccharide in the presence and absence of dexamethasone (1 μM). Supernatants were used for neutrophil chemotaxis assays. SB656933 (2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methyl-furan-2-yl)-propyl]amino]-3,4-dioxo-cyclobut-1-enylamino}-benzamide) (CXCR2 antagonist) and Sch527123 [1-(2-chloro-3-fluorophenyl)-3-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonylphenyl)urea, 3-(2-chloro-3-fluoro-phenyl)-1-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonyl-phenyl)urea] (dual CXCR1 and CXCR2 antagonist) and blocking antibodies for CXCL8, CXCL1, and CCL5 were assessed. Conditioned media caused neutrophil chemotaxis in COPD and smokers (60.5 and 79.9% of total cells, respectively). Dexamethasone did not significantly reduce neutrophil chemotaxis in COPD or S. SB656933 and Sch527123 inhibited chemotaxis in a concentration-dependent manner, with the dual antagonist Sch527123 causing greater inhibition of chemotaxis. CXCL8 antibody inhibited neutrophil chemotaxis to basal levels, although there was no significant effect of blocking either CXCL1 or CCL5 (P > 0.05). CXCL8 plays a major role in neutrophil chemotaxis caused by alveolar macrophage-derived conditioned media, and this is most effectively inhibited by dual antagonism of CXCR1 and CXCR2. Corticosteroids do not inhibit chemotaxis caused by macrophage-derived chemokines.

摘要

肺泡巨噬细胞产生中性粒细胞趋化因子;这种细胞间的串扰有助于慢性阻塞性肺疾病(COPD)中的中性粒细胞气道炎症。我们使用 COPD 肺泡巨噬细胞研究了这些细胞之间的趋化交叉对话机制。使用受刺激的 COPD 肺泡巨噬细胞的条件培养基,我们研究了生长相关癌基因(CXCL1)、白细胞介素 8(CXCL8)和调节激活正常 T 细胞表达和分泌(CCL5)对中性粒细胞趋化的相对贡献,并评估了阻断趋化因子受体 CXCR1 和 CXCR2 对巨噬细胞条件培养基引起的趋化作用的影响。此外,我们评估了刺激的肺泡巨噬细胞中皮质类固醇的治疗是否抑制了条件培养基的趋化能力。从 COPD(n = 8)和吸烟者(S)(n = 8)肺部分离的肺泡巨噬细胞用超纯脂多糖处理,存在和不存在地塞米松(1 μM)。将上清液用于中性粒细胞趋化测定。SB656933(2-羟基-N,N-二甲基-3-[[(R)-1-(5-甲基-呋喃-2-基)丙基]氨基]-3,4-二氧代环丁-1-烯基氨基]-苯甲酰胺)(CXCR2 拮抗剂)和 Sch527123 [1-(2-氯-3-氟苯基)-3-(4-氯-2-羟基-3-哌嗪-1-基磺酰基苯基)脲,3-(2-氯-3-氟苯基)-1-(4-氯-2-羟基-3-哌嗪-1-基磺酰基苯基)脲](双重 CXCR1 和 CXCR2 拮抗剂)和 CXCL8、CXCL1 和 CCL5 的阻断抗体进行了评估。条件培养基引起 COPD 和吸烟者的中性粒细胞趋化(分别为 60.5%和 79.9%的总细胞)。地塞米松对 COPD 或 S 中的中性粒细胞趋化作用无明显抑制作用。SB656933 和 Sch527123 以浓度依赖性方式抑制趋化作用,双重拮抗剂 Sch527123 引起的趋化作用抑制更大。CXCL8 抗体抑制中性粒细胞向基础水平的趋化作用,尽管阻断 CXCL1 或 CCL5 没有明显的效果(P > 0.05)。CXCL8 在肺泡巨噬细胞衍生的条件培养基引起的中性粒细胞趋化中起主要作用,并且这种作用通过 CXCR1 和 CXCR2 的双重拮抗作用最有效地抑制。皮质类固醇不能抑制巨噬细胞衍生趋化因子引起的趋化作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验